Home / News

20.12.16

Season's Greetings

Dear Colleagues and Friends! The “NanoPhoto” Network is deeply thankful for your activity and input to NanoPhoto and CTCT-2016 success and wishes you and your families Merry Christmas and prosperous 2017. It’s time to tank the spiritual energy for further productive work! Sincerely yours, on behalf of “NanoPhoto” Vladimir Sivakov.

20.12.16

CTCT 2017 Save-the-Date

3rd International Conference “Current Trends in Cancer Theranostics-CTCT-2017” will take place on June 25-29, 2017 in Pakruojis Castle/Lithuania. SAVE-the-DATE! See you next year in Lithuania!

20.12.16

Welcome 22nd Partner of the "NanoPhoto" Network

In the frame of the transnational research network "NanoPhoto - Nanotechnology meets Biophotonics" on November 30th, 2016 has been signed a memorandum of understanding between the "NanoPhoto" network and Fraunhofer Institute for Silicate Research ISC in Würzburg/Germany. We are happy to welcome Translation Center Würzburg “Regenerative therapies in oncology and musculoskeletal diseases” and ISC “Theranostics” Group in our multinational Network.

20.12.16

Welcome 21st Partner of the "NanoPhoto" Network

In the frame of the transnational research network "NanoPhoto - Nanotechnology meets Biophotonics" on November 8th, 2016 has been signed a memorandum of understanding between the "NanoPhoto" network and Voronezh State University in Voronezh/Russian Federation. Welcome on board! We hope on fruitful and successful work with our Russian colleagues.

19.11.16

20th Partner of the Network "NanoPhoto-Nanotechnology meets Biophotonics"

In the frame of the transnational research network "NanoPhoto - Nanotechnology meets Biophotonics" has been signed a memorandum of understanding in Almaty/Kazakhstan between the "NanoPhoto" network (represented by the network coordinator Dr. Vladimir Sivakov) and the Nanotechnology Laboratory of the al-Farabi Kazakh National University (represented by the director Dr. Maratbek T. Gabdulin). Since the foundation of the network in August 2014, has been signed cooperation contracts between 19 partner organisations, which provides a very fruitful integration and cooperation between the partners. The new member of the network is the 20th partner institution of the BMBF funded initiative. The success so far, the positive feedback and the high interest in the network clarify the high productivity of the partners of NanoPhoto. In addition to project applications and scientific publications, the international conference "Current Trends in Cancer Theranostics-CTCT" has been established. Furthermore, on the basis of the scientific contacts within the network, joint projects of the partners are to be applied for national and EU Horizon-2020 projects. The network partners have the unique opportunity, to build up an innovative scientific branch and simultaneously contribute an important contribution to the cancer theranostic.

02.07.15

Summer Break

Dear Colleagues! The Baltic Sea Network “NanoPhoto” is deeply thankful for your activity and input to NanoPhoto and CTCT-2015 success and wishes you and your families relaxing summer holidays. It’s time to tank the sun energy for further productive work! Sincerely yours, Vladimir Sivakov and “NanoPhoto” Team.

22.06.15

CTCT-2016 “Save-the-Date”

2nd International Conference “Current Trends in Cancer Theranostics-CTCT-2016” will take place on June 20-22, 2016 in Lithuania. SAVE-the-DATE! See you next in Lithuania!

10.06.15

Second Stage of Baltic Sea Network approved

We are happy to announce that the second stage of the Baltic Sea Network “Nanotechnolopgy meets (Bio)Photonics-NanoPhoto” was approved. The mobility, meetings and joint laboratory activities will be further supported (till February 2016) by Federal Ministry of Education and Research (BMBF). Thank you for your trust in NanoPhoto.

03.06.15

From Regional Workshop to International Conference

Due to the high resonance achieved at CTCT-2015 our meeting was transferred to the 1st International Conference “Current Trends in Cancer Theranostics-CTCT-2015” with yearly periodicity. The 2nd International Conference “Current Trends in Cancer Theranostics-CTCT-2016” will take place in Lithuania under support of National Cancer Institute.

03.06.15

CTCT-2015 closed

The great success and scientific accomplishment was achieved at CTCT-2015. The organizing committee of CTCT-2015 is greatly acknowledged all speakers and poster presenters for high level scientific presentations and discussions. The enormous resonance was reached in short period: new ideas, new partners, new project were initiated at CTCT-2015.

01.06.15

CTCT-2015 Starts

CTCT-2015 after 5 month of organization is started at Leibniz Institute of Photonic Technology in Jena/Germany. The representatives from 12 countries (Germany, France, Russia, UK, Switzerland, Romania, Poland, Armenia, Finland, Ukraine, Lithuania, Estonia) are participating the workshop. Over 50 scientific presentations in nest 2 days are planned. We wish all productive time and new ideas at CTCT-2015.

29.05.15

CTCT-2015 co-funded by STIFT

CTCT-2015 Workshop will be partly co-funded by the Foundation for Technology, Innovation and Research Thuringia (STIFT). The budget was approved. We are thankful for CTCT-2015 support.

01.04.15

CTCT-2015 Call

The submission for CTCT-2015 was closed on March, 31. We received over 40 abstracts from 7 Eurasian countries. The scientific program will be finalized till the end of April. The CTCT-2015 organizing committee wants to thank by all applicants submitted their research topics. The applications for Poster Session can be applied till April 30th, 2015.

31.03.15

Baltic Sea “NanoPhoto” Network at HFSP Foundation

Baltic Sea "NanoPhoto" Network is very pleased to announce that "Interaction of Novel Nanoparticles with Cancer, Stem and Healthy Cells" proposal under Human Frontier Science Program (HFSP) - Research Grant Program" has been submitted. The project is united three European research institutes (Leibniz Institute of Photonic Technology, National Cancer Institute and Institut national des sciences appliquées de Lyon) from Germany, Lithuania and France. Abstract: At presence, there is an enormously growing interest in the research and development of novel drug delivering agents (DDA). Project will deliver an advanced, integrated solution for imaging and therapy of tumour entities by nanoparticle-based multimodal probes, unifying both therapeutic and diagnostic functions. We intend here to carry out a multi-disciplinary project focusing on Si-based and carbon-based nanoparticles (NPs) as DDAs and their visualization using optical imaging modalities. The project vision is to develop and apply Si-based and C-based NPs that can be triggered by physical (ultrasound or ultrahigh-frequency electro-magnetic radiation) and chemical (release of chemotherapeutics) stimuli. This project has a four-fold objectives: (i) NPs synthesis and characterization; (ii) metabolism and toxicity studies of NPs; (iii) in vivo/in vitro visualization of NPs in cancer, stem and healthy cells using confocal microscopy, fluorescence lifetime imaging and Raman microspectroscopy; (iv) implementation of NPs as possible DDA for chemotherapeutics and in vitro response studies of cancer cell exposed with NPs to the electro-magnetic irradiation.

31.03.15

European LOPLAS consortium

Baltic Sea "NanoPhoto" Network is very pleased to announce that "Localized Plasmonic Nanostructures for Smart Sensing Applications "LOPLAS" proposal under Horizon-2020 FET-OPEN "Novel Ideas for Radically New Technologies" has been submitted. LOPLAS is united 7 European (Lithuania, Belarus, Finland, Germany, Hungary, France, and Spain) R&D and SMEA groups. Abstract: The main idea of the LOPLAS project is to create a novel "Handbag-size" tool - a Fluorescence suppressed Raman Spectrometer for food safety monitoring, expanding well beyond traditional technological disciplines. The ambitious scientific, technological breakthrough goal is the development of nanosized structures based on "porous SiOх or Six(ON)y on silicon surface" systems where dielectric pores are selectively filled by noble metals for a formation of dim plasmonic nanostructures - creating a unique "Smart Biosensor" surface. Swift heavy ion track technology and photolithography are used for pre-patterning of porous surfaces with nanoscaled metal particles for highly-sensitive Surface-Enhanced Raman Spectroscopy. Various methods of depositing noble metals and their combinations in the pores (chemical and electrochemical deposition, еlectron beam induced deposition) are applied for the formation of the biosensor gaining high sensitivity in Raman spectroscopy. The characterization of plasmonic structures will be carried out by surface analytic methods like SEM, EDX, EBSD, TEM, etc., which are combined with theoretical modeling of growth processes and plasmonic properties supporting the optimization process of the "Smart Biosensor" Surface. Two companies, high-potential actors in research and innovation, make the "Handbag-size" Fluorescence-Suppressed Raman Spectrometer with an integrated miniature laser and "Smart Biosensor" for high sensitivity food safety monitoring. In parallel to all experimental activities, ongoing technology watch in food safety and food industry monitoring will be carried out to provide an up-to-date assessment of current technical and economic developments and to compare the LOPLAS tool with other new products. A deep synergistic interdisciplinary approach of partners is clearly determined. Clear benefit will be knowledge transfer from research to industry promoting long-term vision and strengthening of European SMEs and food safety.

26.03.15

European Nano_CaT consortium

Baltic Sea "NanoPhoto" Network is very pleased to announce that the first stage "Innovative Nanoparticles based Cancer Therapy "NANO_CaT" proposal under Horizon-2020 NMP Call "Nanomedicine therapy for Cancer" has been submitted. Abstract: Nano_CaT will deliver an advanced, integrated solution for imaging and therapy of tumour entities by using nanoparticlebased multimodal probes, unifying both therapeutic and diagnostic functions. The integration of novel nanoparticles (NPs) into a technological process or processing environment with the potential to yield highly efficient and cost-effective novel NPs as a medical injection/drug and monitoring photoacoustic imaging system is carried out at 5 industry/SMEs and 11 RTD sites from 9 EU member states (Finland, Lithuania, Germany, Hungary, France, Luxembourg, Netherland, Czech Republic, and Romania) and 2 EU associated countries (Ukraine, Israel). The proposed multidisciplinary cooperation between physicists, material scientists, biophysicists, biochemists, physicians and device engineers offers excellent possibilities for the translation of NPs into clinical therapies. The project vision is to develop and apply nano-bio vectors based on silicon and carbon nanostructures as well as upconvertion-based and near infrared emitting phosphors that can be triggered by physical (ultrasound or ultrahigh-frequency electro-magnetic radiation) and chemical (release of chemotherapeutics) stimuli. Through comprehensive in vivo and in vitro pre-clinical studies, the proposal will demonstrate the feasibility of both site-selective delivery and multi-modal functions of bio-conjugated nanoprobes and their efficacy in both systemic and region-selective treatment of cancer. The economic impact of this novel concept of cancer therapy refers to finding new and modern therapeutic solutions that will hopefully lead to an improved therapeutic index for the patient diagnosed with non-Hodgkin's lymphoma, metastatic melanoma and neuroendocrine tumour compared to the present medicated treatments. Such intelligent therapeutics should lower dose of active cancer therapeutic agent, modulate release and prolong impact period of drug to tumour and reduce direct and indirect healthcare costs at hospitals.

01.03.15

Nanomedicine oriented Workshop on June 1-3, 2015 in Jena/Germany

We are pleasure to announce the "Current Trends in Cancer Theranostics-CTCT-2015" international workshop on June 1-3, 2015 at Leibniz Institute of Photonic Technology in Jena/Germany. Workshop will be focused on innovations in area of drug delivery systems, bioimaging and clinical/pre-clinical therapy of oncology diseases. The philosophy of CTCT-2015 is focused on bringing together leading scientists from different scientific fields working on development, and testing of novel nanostructures such like upconverting, silicon-based and carbon-based nanostructures for cancer research (visualization and cancer therapy).

For more details, please see: http://www.nanophoto.de/index.php?id=3

16.02.15

M-Era.net Transnational "Sil-Med" Consortium

The Baltic Sea Network "NanoPhoto" is pleased to inform that Pre-proposal 'Innovative Silicon Nanostructure for Medical Applications: Drug Delivery and Cancer Theranostics (Sil-Med)' under M-Era.net Transnational Call 2014 has been recommended for Full Proposal submission. The proposed project demands the multi-disciplinary cooperation - a consortium comprised of German (Leibniz Institute of Photonic Technology, SME iThera Medical GmbH), Lithuanian (National Cancer Institute) and Taiwanese (National Dong Hwa University) partners - between physicists, material scientists, biophysicists, biochemists, medicine doctors and device engineers offers excellent possibilities for the implementation of new application fields for nanoparticles in medicine. The full proposal was successfully submitted on February 16th, 2015.

11.12.14

New Baltic Sea Network ”NanoPhoto” Partners

Nanophoto is very pleased to welcome a new network members from Institut National des Sciences Appliquées de Lyon, Lyon/France represented by Dr. Alain Geloen and Dr. Vladimir Lysenko (http://www.nanophoto.de/index.php?id=154); Biophotonics Group at Oulu University, Oulu/Finland represented by Prof. Igor Meglinski (http://www.nanophoto.de/index.php?id=150) and Iuliu Hatieganu University of Medicine and Pharmacy&Ion Chiricuta Comprehensive Cancer Center, Cluj/Romania represented by Dr. Ciprian Tomuleasa (http://www.nanophoto.de/index.php?id=155). New partners will support the partners in scientific areas of bioimaging, cell biology and preclinical/clinical tumor studies

10.12.14

First Network Meeting

The first Baltic Sea "NanoPhoto" Network Meeting will take place on 10-12th of December, 2014 at Leibniz Institute of Photonic Technology. The philosophy of network is focused on bringing together scientists from network 'NanoPhoto' and development, and testing of novel nanostructure such like upconverting, silicon-based and carbon-based nanostructures for cancer research (vizualization and cancer therapy). Here, we will have a focus on the development of different nanostructures that most efficiently permit to develop novel knowledge for cancer research. The partners from Germany, Sweden, Finland, Lithuania, France and Russia involved in "NanoPhoto" are all from the areas of materials science, physics, chemistry and medicine and are thus most ideally suited to develop the aforementioned materials and devices for bio-photonic applications.

02.12.14

ERA.NET RUS PLUS “SIL_THERA” Consortium

Baltic Sea "NanoPhoto" Network is very pleased to announce that the first stage "Biocompatible silicon-based nanostructures for tumor visualization and therapy - Sil-Thera" proposal - for a consortium comprised of German (Leibniz Institute of Photonic Technology), Romanian (Ion Chiricuta Oncology Institute; University of Medicine and Pharmacy IuliuHatieganu; SC Santomar Oncodiagnostic Ltd) and Russian (Center of Expert Technologies of Lomonosov Moscow State University Ltd.) partners - has been recently selected for full proposal submission by ERA.NE RUS PLUS Consortium. Silicon nanoparticles visualization technique and silicon-based therapy tested/developed in this project is primarily an enabling tool for scientists and medicine and will foster the research and development of cancer theranostics based applications in cancer treatment fields. For the first time, R&D teams will have the possibility for the pre-clinical studies of non‐invasive cancer cell theranostic modalities based on silicon nanostructures. The efficiency of silicon based therapy will be investigated. The full proposal was successfully submitted on December 1st, 2014.

527efb333